These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 9333146)

  • 1. A randomized, double-blind, placebo-controlled trial of cidofovir gel for the treatment of acyclovir-unresponsive mucocutaneous herpes simplex virus infection in patients with AIDS.
    Lalezari J; Schacker T; Feinberg J; Gathe J; Lee S; Cheung T; Kramer F; Kessler H; Corey L; Drew WL; Boggs J; McGuire B; Jaffe HS; Safrin S
    J Infect Dis; 1997 Oct; 176(4):892-8. PubMed ID: 9333146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acyclovir-resistant herpes: expanded access available for cidofovir gel (Forvade).
    AIDS Treat News; 1997 Feb; (No 264):5. PubMed ID: 11364104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC).
    Snoeck R; Andrei G; Gérard M; Silverman A; Hedderman A; Balzarini J; Sadzot-Delvaux C; Tricot G; Clumeck N; De Clercq E
    Clin Infect Dis; 1994 Apr; 18(4):570-8. PubMed ID: 8038312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of foscarnet-resistant herpes simplex stomatitis with intravenous cidofovir in a child.
    Bryant P; Sasadeusz J; Carapetis J; Waters K; Curtis N
    Pediatr Infect Dis J; 2001 Nov; 20(11):1083-6. PubMed ID: 11734717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter phase I/II dose escalation study of single-dose cidofovir gel for treatment of recurrent genital herpes.
    Sacks SL; Shafran SD; Diaz-Mitoma F; Trottier S; Sibbald RG; Hughes A; Safrin S; Rudy J; McGuire B; Jaffe HS
    Antimicrob Agents Chemother; 1998 Nov; 42(11):2996-9. PubMed ID: 9797239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of acyclovir-resistant, foscarnet-unresponsive HSV infection with topical cidofovir in a child with AIDS.
    Lateef F; Don PC; Kaufmann M; White SM; Weinberg JM
    Arch Dermatol; 1998 Sep; 134(9):1169-70. PubMed ID: 9762047
    [No Abstract]   [Full Text] [Related]  

  • 7. Cidofovir use in acyclovir-resistant herpes infection.
    Martinez CM; Luks-Golger DB
    Ann Pharmacother; 1997 Dec; 31(12):1519-21. PubMed ID: 9416391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infection due to acyclovir resistant herpes simplex virus in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Venard V; Dauendorffer JN; Carret AS; Corsaro D; Edert D; Bordigoni P; Le Faou A
    Pathol Biol (Paris); 2001 Sep; 49(7):553-8. PubMed ID: 11642018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful clearance of cutaneous acyclovir-resistant, foscarnet-refractory herpes virus lesions with topical cidofovir in an allogeneic hematopoietic stem cell transplant patient.
    Muluneh B; Dean A; Armistead P; Khan T
    J Oncol Pharm Pract; 2013 Jun; 19(2):181-5. PubMed ID: 22635417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with intravenous (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]-cytosine of acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with AIDS.
    Lalezari JP; Drew WL; Glutzer E; Miner D; Safrin S; Owen WF; Davidson JM; Fisher PE; Jaffe HS
    J Infect Dis; 1994 Sep; 170(3):570-2. PubMed ID: 8077713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of cidofovir in an HIV infected patient with an acyclovir and foscarnet resistant herpes simplex virus infection].
    Saint-Léger E; Fillet AM; Malvy D; Rabanel B; Caumes E
    Ann Dermatol Venereol; 2001; 128(6-7):747-9. PubMed ID: 11460038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of an acyclovir- and foscarnet-resistant herpes simplex virus type 1 lesion with intravenous cidofovir.
    LoPresti AE; Levine JF; Munk GB; Tai CY; Mendel DB
    Clin Infect Dis; 1998 Feb; 26(2):512-3. PubMed ID: 9502489
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of acyclovir-resistant herpes simplex virus.
    Chilukuri S; Rosen T
    Dermatol Clin; 2003 Apr; 21(2):311-20. PubMed ID: 12757254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of an acyclovir and foscarnet-resistant herpes simplex virus infection with cidofovir in a child after an unrelated bone marrow transplant.
    Blot N; Schneider P; Young P; Janvresse C; Dehesdin D; Tron P; Vannier JP
    Bone Marrow Transplant; 2000 Oct; 26(8):903-5. PubMed ID: 11081393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of HIV-infected patients once diagnosed with acyclovir-resistant herpes simplex virus infection.
    Seang S; Boutolleau D; Burrel S; Regnier S; Epelboin L; Voujon D; Valantin MA; Katlama C; Agut H; Caumes E
    Int J STD AIDS; 2014 Aug; 25(9):676-82. PubMed ID: 24535691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Azone upon the in vivo antiviral efficacy of cidofovir or acyclovir topical formulations in treatment/prevention of cutaneous HSV-1 infections and its correlation with skin target site free drug concentration in hairless mice.
    Afouna MI; Fincher TK; Zaghloul AA; Reddy IK
    Int J Pharm; 2003 Mar; 253(1-2):159-68. PubMed ID: 12593946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative antiviral efficacies of cidofovir, trifluridine, and acyclovir in the HSV-1 rabbit keratitis model.
    Romanowski EG; Bartels SP; Gordon YJ
    Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):378-84. PubMed ID: 9950596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of cutaneous human papilloma virus, poxvirus and herpes simplex virus infections with topical cidofovir in HIV positive patients].
    Toutous-Trellu L; Hirschel B; Piguet V; Schiffer V; Saurat JH; Pechère M
    Ann Dermatol Venereol; 2004 May; 131(5):445-9. PubMed ID: 15235531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group.
    Safrin S; Crumpacker C; Chatis P; Davis R; Hafner R; Rush J; Kessler HA; Landry B; Mills J
    N Engl J Med; 1991 Aug; 325(8):551-5. PubMed ID: 1649971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of an aciclovir-resistant herpes simplex type 2 infection with cidofovir in an AIDS patient.
    Kopp T; Geusau A; Rieger A; Stingl G
    Br J Dermatol; 2002 Jul; 147(1):134-8. PubMed ID: 12100196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.